160 related articles for article (PubMed ID: 32201370)
1. Enzyme replacement in advanced pancreatic cancer: patient perceptions.
Landers A; McKenzie C; Pitama SG; Brown H
BMJ Support Palliat Care; 2023 Oct; 13(e1):e122-e128. PubMed ID: 32201370
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic enzyme replacement therapy following surgery for pancreatic cancer: An exploration of patient self-management.
Dunleavy L; Al-Mukhtar A; Halliday V
Clin Nutr ESPEN; 2018 Aug; 26():97-103. PubMed ID: 29908691
[TBL] [Abstract][Full Text] [Related]
3. Frequency of Appropriate Use of Pancreatic Enzyme Replacement Therapy and Symptomatic Response in Pancreatic Cancer Patients.
Barkin JA; Westermann A; Hoos W; Moravek C; Matrisian L; Wang H; Shemanski L; Barkin JS; Rahib L
Pancreas; 2019 Jul; 48(6):780-786. PubMed ID: 31210656
[TBL] [Abstract][Full Text] [Related]
4. Impact of the treatment of pancreatic exocrine insufficiency on survival of patients with unresectable pancreatic cancer: a retrospective analysis.
Domínguez-Muñoz JE; Nieto-Garcia L; López-Díaz J; Lariño-Noia J; Abdulkader I; Iglesias-Garcia J
BMC Cancer; 2018 May; 18(1):534. PubMed ID: 29728096
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic enzyme replacement therapy (PERT) for malabsorption in patients with metastatic pancreatic cancer.
Landers A; Muircroft W; Brown H
BMJ Support Palliat Care; 2016 Mar; 6(1):75-9. PubMed ID: 25164613
[TBL] [Abstract][Full Text] [Related]
6. Expert opinion on management of pancreatic exocrine insufficiency in pancreatic cancer.
Roeyen G; Berrevoet F; Borbath I; Geboes K; Peeters M; Topal B; Van Cutsem E; Van Laethem JL
ESMO Open; 2022 Feb; 7(1):100386. PubMed ID: 35124465
[TBL] [Abstract][Full Text] [Related]
7. Real-World Patient Experience With Pancreatic Enzyme Replacement Therapy in the Treatment of Exocrine Pancreatic Insufficiency.
Barkin JA; Harb D; Kort J; Barkin JS
Pancreas; 2024 Jan; 53(1):e16-e21. PubMed ID: 38039440
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic Enzyme Replacement Therapy for Patients Diagnosed With Pancreaticobiliary Cancer: Validation of an Algorithm for Dose Escalation and Management.
Carnie LE; Farrell K; Barratt N; Abraham M; Gillespie L; Satyadas T; McNamara MG; Hubner RA; Geraghty J; Bibby N; Valle JW; Lamarca A
Pancreas; 2021 Oct; 50(9):1254-1259. PubMed ID: 34860808
[TBL] [Abstract][Full Text] [Related]
9. Exocrine pancreatic insufficiency following esophagectomy.
Huddy JR; Macharg FM; Lawn AM; Preston SR
Dis Esophagus; 2013 Aug; 26(6):594-7. PubMed ID: 23199208
[TBL] [Abstract][Full Text] [Related]
10. The use of pancreatic enzyme replacement therapy in patients with a diagnosis of chronic pancreatitis and pancreatic cancer in the US is infrequent and inconsistent.
Forsmark CE; Tang G; Xu H; Tuft M; Hughes SJ; Yadav D
Aliment Pharmacol Ther; 2020 May; 51(10):958-967. PubMed ID: 32249970
[TBL] [Abstract][Full Text] [Related]
11. Gut microbiome as a response marker for pancreatic enzyme replacement therapy in a porcine model of exocrine pancreas insufficiency.
Ritz S; Hahn D; Wami HT; Tegelkamp K; Dobrindt U; Schnekenburger J
Microb Cell Fact; 2020 Dec; 19(1):221. PubMed ID: 33272255
[TBL] [Abstract][Full Text] [Related]
12. The Impact of Pancreatic Enzyme Replacement Therapy on Patients With Advanced Pancreatic Adenocarcinoma: A Systematic Review and Narrative Synthesis.
Landers A; Donaldson F; Brown H; McKenzie C; Pendharkar S
Pancreas; 2022 May; 51(5):405-414. PubMed ID: 35973015
[TBL] [Abstract][Full Text] [Related]
13. Impact of pancreatic enzyme replacement therapy on short- and long-term outcomes in advanced pancreatic cancer: meta-analysis of randomized controlled trials.
Ammar K; Leeds JS; Ratnayake CB; Sen G; French JJ; Nayar M; Oppong KW; Loveday BP; Pandanaboyana S
Expert Rev Gastroenterol Hepatol; 2021 Aug; 15(8):941-948. PubMed ID: 33522321
[No Abstract] [Full Text] [Related]
14. Exocrine Pancreatic Insufficiency Dosing Guidelines for Pancreatic Enzyme Replacement Therapy Vary Widely Across Disease Types.
Lewis DM; Rieke JG; Almusaylim K; Kanchibhatla A; Blanchette JE; Lewis C
Dig Dis Sci; 2024 Feb; 69(2):615-633. PubMed ID: 38117426
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic Enzyme Replacement Therapy in Patients with Non-pancreatic Digestive Conditions: A Nationwide Claims Analysis.
Phillips AE; Tang G; Wang X; Forsmark CE; Yadav D
Dig Dis Sci; 2023 May; 68(5):1754-1761. PubMed ID: 36370243
[TBL] [Abstract][Full Text] [Related]
16. Contribution of pancreatic enzyme replacement therapy to survival and quality of life in patients with pancreatic exocrine insufficiency.
Layer P; Kashirskaya N; Gubergrits N
World J Gastroenterol; 2019 May; 25(20):2430-2441. PubMed ID: 31171887
[TBL] [Abstract][Full Text] [Related]
17. Glycemic Variability Assessment in Newly Treated Exocrine Pancreatic Insufficiency With Type 1 Diabetes.
Lewis DM; Shahid A
J Diabetes Sci Technol; 2024 Mar; 18(2):430-437. PubMed ID: 35787705
[TBL] [Abstract][Full Text] [Related]
18. Pancreas exocrine replacement therapy is associated with increased survival following pancreatoduodenectomy for periampullary malignancy.
Roberts KJ; Schrem H; Hodson J; Angelico R; Dasari BVM; Coldham CA; Marudanayagam R; Sutcliffe RP; Muiesan P; Isaac J; Mirza DF
HPB (Oxford); 2017 Oct; 19(10):859-867. PubMed ID: 28711377
[TBL] [Abstract][Full Text] [Related]
19. Prescription patterns of pancreatic enzyme replacement therapy for patients with pancreatic cancer in the United States.
Jain T; Sharma P; Giri B; Iyer S; Sethi V; Bava EP; Vaish U; Sahay P; Datta J; Reddy S; Bart Rose J; Khan A; Merchant N; Chari ST; Dudeja V
HPB (Oxford); 2022 Oct; 24(10):1729-1737. PubMed ID: 35717430
[TBL] [Abstract][Full Text] [Related]
20. Adherence to pancreatic enzyme replacement therapy among patients with chronic pancreatitis in East China: a mixed methods study.
Zhou Y; Huang RQ; Wu QW; Xu JJ; Yi JH; Chen C; Lu GT; Li ZS; Wang D; Hu LH
Sci Rep; 2023 Oct; 13(1):17147. PubMed ID: 37816878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
